Corestem Overview

  • Founded
  • 2003
Founded
  • Status
  • Public
  • Employees
  • 69
Employees
  • Stock Symbol
  • 166480
Stock Symbol
  • Share Price
  • $15.81
  • (As of Thursday Closing)

Corestem General Information

Description

Corestem Inc is a South Korea based company biopharmaceutical company. It is primarily engaged in the business activity of developing and producing stem cell therapy for the treatment of incurable diseases. The company's NEURONATA-R inj., a stem cell therapy, is for Lou Gehrig's disease which is a rare incurable disease. In addition to the therapy of Lou Gehrig's disease, it also has a pipeline of therapies for various diseases such as lupus, multiple system atrophy, and osteoarthritis.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Drug Delivery
Stock Exchange
KRX
Primary Office
  • Number 1008, Number 902, Number 401 (the holy one, SK Techno Building)
  • 133-710 gu, holy days 55
  • Seoul, 04779
  • South Korea
+82 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Corestem Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$15.81 $16.19 $13.64 - $26.34 $249M 15.7M 222K -$1.73

Corestem Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 243,052 291,120 108,079 147,575
Revenue 25,071 22,324 20,826 20,304
EBITDA (14,991) (10,647) (593) (1,101)
Net Income (27,212) (19,638) (4,432) (3,091)
Total Assets 122,392 130,964 73,940 79,820
Total Debt 21,963 18,479 759 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Corestem Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Corestem‘s full profile, request access.

Request a free trial

Corestem Executive Team (2)

Name Title Board Seat Contact Info
Gyeong Kim Co-Chief Executive Officer & Board Member
Kyung Suk Kim Co-Chief Executive Officer
To view Corestem’s complete executive team members history, request access »

Corestem Board Members (1)

Name Representing Role Since
Gyeong Kim Corestem Co-Chief Executive Officer & Board Member 000 0000
To view Corestem’s complete board members history, request access »

Corestem Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Corestem Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Corestem‘s full profile, request access.

Request a free trial